Sibel Doğan

652 total citations
59 papers, 302 citations indexed

About

Sibel Doğan is a scholar working on Dermatology, Immunology and Rheumatology. According to data from OpenAlex, Sibel Doğan has authored 59 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Dermatology, 19 papers in Immunology and 13 papers in Rheumatology. Recurrent topics in Sibel Doğan's work include Psoriasis: Treatment and Pathogenesis (13 papers), Dermatology and Skin Diseases (7 papers) and Drug-Induced Adverse Reactions (5 papers). Sibel Doğan is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (13 papers), Dermatology and Skin Diseases (7 papers) and Drug-Induced Adverse Reactions (5 papers). Sibel Doğan collaborates with scholars based in Türkiye, United States and Germany. Sibel Doğan's co-authors include Nilgün Atakan, Nilgün Atakan, Neslihan Akdoğan, Sibel Ersoy Evans, Ayşen Karaduman, Başak Yalçın, Sevtap Arıkan-Akdağlı, Murat Akova, Ali Akdoğan and Başak Yalıcı‐Armağan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Medicine and Clinical Immunology.

In The Last Decade

Sibel Doğan

51 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sibel Doğan Türkiye 11 108 64 63 52 49 59 302
Müge Güler Özden Türkiye 12 132 1.2× 91 1.4× 65 1.0× 41 0.8× 26 0.5× 28 368
Ayşe Esra Koku Aksu Türkiye 11 241 2.2× 59 0.9× 41 0.7× 80 1.5× 53 1.1× 62 390
Neslihan Akdoğan Türkiye 10 158 1.5× 56 0.9× 58 0.9× 47 0.9× 28 0.6× 56 272
A. Yasmine Kirkorian United States 10 141 1.3× 39 0.6× 36 0.6× 71 1.4× 74 1.5× 52 372
Didem Didar Balcı Türkiye 9 174 1.6× 95 1.5× 30 0.5× 44 0.8× 18 0.4× 26 306
Ana Filipa Duarte Portugal 10 101 0.9× 26 0.4× 50 0.8× 87 1.7× 71 1.4× 41 273
Mehdi Gheisari Iran 10 185 1.7× 22 0.3× 37 0.6× 28 0.5× 62 1.3× 42 326
Parvaneh Hatami Iran 11 168 1.6× 87 1.4× 51 0.8× 29 0.6× 125 2.6× 58 352
Esteban Fernández Faith United States 9 120 1.1× 30 0.5× 38 0.6× 57 1.1× 73 1.5× 43 419
Betül Karaatmaca Türkiye 13 57 0.5× 139 2.2× 84 1.3× 42 0.8× 27 0.6× 40 431

Countries citing papers authored by Sibel Doğan

Since Specialization
Citations

This map shows the geographic impact of Sibel Doğan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sibel Doğan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sibel Doğan more than expected).

Fields of papers citing papers by Sibel Doğan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sibel Doğan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sibel Doğan. The network helps show where Sibel Doğan may publish in the future.

Co-authorship network of co-authors of Sibel Doğan

This figure shows the co-authorship network connecting the top 25 collaborators of Sibel Doğan. A scholar is included among the top collaborators of Sibel Doğan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sibel Doğan. Sibel Doğan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Doğan, Sibel, et al.. (2024). The Impact of Diet on Hidradenitis Suppurativa Severity: A Cross-Sectional Case–Control Study. Medicina. 60(12). 2107–2107. 1 indexed citations
4.
Bostan, Ecem, Neslihan Akdoğan, Başak Yalıcı‐Armağan, et al.. (2022). Monitoring Serum Lipid Profile and Liver Transaminase Levels During Isotretinoin Therapy. 53(2). 110–113. 2 indexed citations
5.
Doğan, Sibel, et al.. (2022). Comparison of early (EOP) and late onset psoriasis (LOP) regarding systemic inflammatory comorbidities: LOP is a more rapid subtype of psoriasis. Dermatology Practical & Conceptual. 12(3). e2022144–e2022144. 2 indexed citations
6.
Yalıcı‐Armağan, Başak, et al.. (2022). Dermatology consultation requests from a university hospital's pediatric and adult emergency departments: A 5-year retrospective analysis. The American Journal of Emergency Medicine. 53. 112–117. 2 indexed citations
7.
Akdoğan, Neslihan, Sibel Doğan, Ecem Bostan, et al.. (2021). Age and psoriatic arthritis are important predictors of biologic agent switch in psoriasis. Expert Review of Clinical Pharmacology. 14(12). 1535–1541. 4 indexed citations
8.
Yalıcı‐Armağan, Başak, et al.. (2021). Treatment of psoriasis with biologics in the early COVID‐19 pandemic: A study examining patient attitudes toward the treatment and disease course. Journal of Cosmetic Dermatology. 20(10). 3098–3102. 4 indexed citations
9.
Akdoğan, Neslihan, et al.. (2021). Comparison of rituximab and intravenous immunoglobulin in the treatment of autoimmune bullous diseases: Real‐life data from a single centre. International Journal of Clinical Practice. 75(12). e14955–e14955. 1 indexed citations
10.
Akdoğan, Neslihan, et al.. (2021). Sarcoid-like granulomatous reaction in the lung mimicking miliary tuberculosis in a patient receiving adalimumab for psoriasis. Archives of Rheumatology. 36(3). 461–463. 1 indexed citations
11.
Bostan, Ecem, Sibel Doğan, Başak Yalıcı‐Armağan, et al.. (2020). Lactate dehydrogenase, Beta-2 Microglobulin Levels and CD4/CD8 Lymphocyte Ratio in Patients with Mycosis Fungoides in Stage 1A. 51(4). 16–21. 2 indexed citations
12.
Akdoğan, Neslihan, Sibel Doğan, Başak Yalıcı‐Armağan, et al.. (2020). Serial Quantiferon‐TB Gold test results in 279 patients with psoriasis receiving biologic therapy. Dermatologic Therapy. 34(1). e14699–e14699. 5 indexed citations
13.
Doğan, Sibel, et al.. (2019). Pustular Activation of Plaque Psoriasis İnduced After Hepatitis B Vaccination. SHILAP Revista de lepidopterología. 13(1). 46–48.
14.
Doğan, Sibel, et al.. (2019). Case of Erythema Multiforme Associated with Pustules: Coexistence of Erythema Multiforme Minor and Acute Generalized Exanthamatous Pustulosis. Turkish Journal of Dermatology. 13(1). 16–19. 1 indexed citations
15.
Akdoğan, Neslihan, Sibel Doğan, & Nilgün Atakan. (2019). Long-term effects of biologic therapies on peripheral blood eosinophils in patients with psoriasis: a 3-year single-center study. Journal of Dermatological Treatment. 31(7). 702–706. 3 indexed citations
16.
Akdoğan, Neslihan, Sibel Doğan, Erdem Karabulut, et al.. (2019). Serum amyloid A and C-reactive protein levels and erythrocyte sedimentation rate are important indicators in hidradenitis suppurativa. Archives of Dermatological Research. 312(4). 255–262. 12 indexed citations
17.
Esenboğa, Saliha, Betül Karaatmaca, Baran Erman, et al.. (2018). Two siblings with PRKDC defect who presented with cutaneous granulomas and review of the literature. Clinical Immunology. 197. 1–5. 18 indexed citations
18.
Evans, Sibel Ersoy, et al.. (2016). Diaper Dermatitis: A Review of 63 Children. Pediatric Dermatology. 33(3). 332–336. 20 indexed citations
19.
Allı, Nuran & Sibel Doğan. (2015). Short-term isotretinoin-induced elkonyxis and median nail dystrophy. Cutaneous and Ocular Toxicology. 35(1). 85–86. 6 indexed citations
20.
Atakan, Nilgün & Sibel Doğan. (2012). Psoriasis, a Systemic Disease?. SHILAP Revista de lepidopterología. 6(3). 123–126. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026